Clinical trial
Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases
NCT00328575 · Sidney Kimmel Cancer Center at Thomas Jefferson University, Other · Completed
Key facts
| NCT number | NCT00328575 |
|---|---|
| Title | Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases |
| Official title | Phase I Dose Escalation Trial in Patients With Brain Metastases Using IMRT |
| Lead sponsor | Sidney Kimmel Cancer Center at Thomas Jefferson University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasm Metastasis |
| Intervention type | Radiation |
| Interventions | Intensity-Modulated Radiotherapy (IMRT) |
| Enrollment | 10 |
| Start date | Oct 1, 2005 |
| Primary completion | Jul 1, 2009 |
| Completion | Jun 1, 2011 |
| First posted | May 22, 2006 |
| Last update posted | Oct 21, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: